HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endocardial cushion defect in a patient with Crouzon syndrome carrying a mutation in the fibroblast growth factor receptor (FGFR)-2 gene.

Abstract
Crouzon syndrome is an autosomal dominant disorder caused by mutation in the fibroblast growth factor receptor (FGFR)-2 gene. Recent findings from animal studies imply a critical role for FGFs in the regulation of cardiac development including cardiac cushion proliferation and valvulogenesis. We report on a 36-year-old woman, who required surgical closure for an atrial septal defect, a clinical feature that has not been previously reported in other patients with Crouzon syndrome. The findings suggest that cardiac investigations are warranted in patients with a diagnosis of Crouzon syndrome.
AuthorsC Schulz, W Kress, A Schömig, R Wessely
JournalClinical genetics (Clin Genet) Vol. 72 Issue 4 Pg. 305-7 (Oct 2007) ISSN: 0009-9163 [Print] Denmark
PMID17850625 (Publication Type: Case Reports, Journal Article)
Chemical References
  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2
Topics
  • Adult
  • Cell Proliferation
  • Craniofacial Dysostosis (diagnosis, genetics)
  • Echocardiography (methods)
  • Endocardial Cushion Defects (genetics)
  • Female
  • Gene Expression Regulation
  • Genes, Dominant
  • Humans
  • Mutation
  • Phenotype
  • Receptor, Fibroblast Growth Factor, Type 2 (genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: